trial · primary record
Survodutide
Metabolic Dysfunction Associated Steatohepatitis (MASH)
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1800 |
| Primary completion | 2031-12-27 |
| Primary endpoint | Part 1: Resolution of MASH without worsening of liver fibrosis on MASH Clinical Research Network (CRN) fibrosis score |
| Registry ID | NCT06632444 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:43:08.190Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06632444
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Survodutide · compound